ATG9A and AP-4 deficiency syndrome: These findings thus establish AP-4 ε KO mice as a suitable animal model for human AP-4 deficiency syndrome, and indicate that mislocalization of ATG9A and impaired degradation of intracellular aggregates might contribute to the pathogenesis of this disorder.